Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.

GREY:ISOLF - Post by User

Isodiol International Inc

Bullboard Posts

Comment by MrPumpandDump1on Dec 22, 2017 5:42am

26 Views

Post# 27212559

RE:RE:30M finance ?

Nothing but positives with Isol. GREEN day today. Cheers

Kevelle wrote:
Its FANTASTIC news for ISOL and shareholders. The $30MM capital will be utilized to continue international expansion and to fund strategic initiatives as it expands its global reach.

Aaron Nathaniel Serruya of Serruya Equity stated, “We are pleased to participate in yet another round of funding for Isodiol. Isodiol continues to impress us with innovation and global reach. We expect great things from the Company, including their recent successful launch of a non-cannabis based CBD derived from two specific strains of hops and their pending acquisition of Biosynthesis Pharma Group.”

$0 debt
$60MM revenue guidance 2018
$50MM cash in hand
$25MM LOC available for future growth requirements
LONG
gLTa